IM Cannabis Sells European Assets to CEO-Controlled Slil in $3M Equity Boost
Event summary
- IM Cannabis to sell IMC Holdings and European-focused assets to Slil.com Holding Ltd. for CAD$3M in equity improvement.
- Transaction includes Slil assuming up to CAD$9.4M in retained liabilities.
- Closing expected by September 30, 2026, subject to regulatory approvals.
- IM Cannabis will retain Israeli medical cannabis operations post-transaction.
- Deal structured as a related-party transaction under MI 61-101 exemptions.
The big picture
IM Cannabis's sale of European assets to a CEO-controlled entity highlights its strategic pivot toward core Israeli operations amid financial distress. The transaction, structured under regulatory exemptions, reflects broader industry trends of consolidation and restructuring in the medical cannabis sector. The deal's success hinges on IM Cannabis's ability to streamline its corporate structure while managing related-party transaction risks.
What we're watching
- Financial Health
- Whether the CAD$3M equity improvement will sufficiently address IM Cannabis's financial difficulties.
- Regulatory Compliance
- The pace at which IM Cannabis secures necessary approvals for the transaction.
- Operational Focus
- How IM Cannabis's shift to Israeli medical cannabis operations will impact its market position.